PharmaBlock Sciences Nanjing Inc Class A (300725) — Cash Flow Quality Index
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Cash Flow Quality Index of 2.04x as of September 2025. Operating cash flow of CN¥83.36 Million exceeds net income of CN¥40.89 Million, indicating high earnings quality where cash backs reported profits. Explore PharmaBlock Sciences Nanjing Inc Class A (300725) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmaBlock Sciences Nanjing Inc Class A Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for PharmaBlock Sciences Nanjing Inc Class A across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of PharmaBlock Sciences Nanjing Inc Class A.
Annual Cash Flow Quality Index for PharmaBlock Sciences Nanjing Inc Class A (2013–2025)
Year-by-year earnings quality comparison for PharmaBlock Sciences Nanjing Inc Class A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.63x | CN¥667.36 Million | CN¥183.74 Million | ▲ +163.3% |
| 2024 | 1.38x | CN¥302.82 Million | CN¥219.54 Million | ▲ +10.3% |
| 2023 | 1.25x | CN¥246.84 Million | CN¥197.36 Million | ▲ +65.3% |
| 2022 | 0.76x | CN¥246.61 Million | CN¥325.89 Million | ▲ +60.2% |
| 2021 | 0.47x | CN¥238.03 Million | CN¥503.77 Million | ▼ -67.9% |
| 2020 | 1.47x | CN¥271.51 Million | CN¥184.20 Million | ▲ +76.4% |
| 2019 | 0.84x | CN¥127.04 Million | CN¥152.07 Million | ▼ -29.8% |
| 2018 | 1.19x | CN¥160.16 Million | CN¥134.50 Million | ▲ +47.7% |
| 2017 | 0.81x | CN¥54.64 Million | CN¥67.79 Million | ▲ +24.1% |
| 2016 | 0.65x | CN¥22.76 Million | CN¥35.04 Million | ▼ -53.1% |
| 2015 | 1.39x | CN¥27.52 Million | CN¥19.86 Million | ▲ +161.4% |
| 2014 | 0.53x | CN¥11.91 Million | CN¥22.46 Million | ▼ -47.2% |
| 2013 | 1.00x | CN¥18.32 Million | CN¥18.25 Million | — |